HealthEquity (NASDAQ:HQY) EVP Michael Henry Fiore Sells 3,142 Shares

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 3,142 shares of the firm’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. This represents a 5.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

HealthEquity Trading Down 2.5%

Shares of HQY stock opened at $88.34 on Wednesday. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm’s 50 day moving average is $83.63 and its 200 day moving average is $86.61. The stock has a market capitalization of $7.39 billion, a P/E ratio of 33.09, a P/E/G ratio of 1.55 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts expect that HealthEquity, Inc. will post 3.84 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on HQY. Barclays dropped their target price on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. BTIG Research dropped their target price on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft raised their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Barrington Research restated an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd. Finally, KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $111.53.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Capricorn Fund Managers Ltd bought a new stake in shares of HealthEquity during the 4th quarter valued at $6,926,000. 12th Street Asset Management Company LLC raised its position in shares of HealthEquity by 114.4% during the 3rd quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock valued at $25,784,000 after purchasing an additional 145,151 shares during the period. Oppenheimer Asset Management Inc. raised its position in shares of HealthEquity by 45.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock valued at $14,741,000 after purchasing an additional 48,621 shares during the period. Bessemer Group Inc. raised its position in shares of HealthEquity by 21.3% during the 3rd quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock valued at $33,108,000 after purchasing an additional 61,317 shares during the period. Finally, King Luther Capital Management Corp raised its position in shares of HealthEquity by 60.6% during the 3rd quarter. King Luther Capital Management Corp now owns 80,584 shares of the company’s stock valued at $7,637,000 after purchasing an additional 30,394 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.